Supreme Pharmaceuticals Inc (TSE:FIRE) had its price target lifted by investment analysts at Canaccord Genuity from C$2.00 to C$2.15 in a research report issued to clients and investors on Thursday.

WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/12/supreme-pharmaceuticals-inc-fire-given-new-c2-15-price-target-at-canaccord-genuity.html.

Receive News & Ratings for Supreme Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Supreme Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.